Text Size

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Weill Medical College of Cornell University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00151203
First received: September 6, 2005
Last updated: December 18, 2009
Last verified: December 2009
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
No publications provided by Weill Medical College of Cornell University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):